feed,title,long_url,short_url
Benzinga,"FDA To Miss Action Dates For AbbVie's Upadacitinib Application For Psoriatic Arthritis, Ankylosing Spondylitis",https://benzinga.com/general/biotech/21/06/21723762/fda-to-miss-action-dates-for-abbvies-upadacitinib-application-for-psoriatic-arthritis-ankylosing-,https://j.mp/3xNC5Im
Benzinga,EMA's Advisory Committee Backs Approval Of BioMarin's Dwarfism Candidate,https://benzinga.com/general/biotech/21/06/21722234/emas-advisory-committee-backs-approval-of-biomarins-dwarfism-candidate,https://j.mp/3zYriwX
